IXICO PLC has strengthened its scientific advisory board by adding three senior specialists in Alzheimer’s and Parkinson’s diseases. The company also launched a new research collaboration with the Paris Brain Institute to improve MRI imaging techniques for Parkinson’s clinical trials using AI-driven analysis. This expansion and partnership aim to enhance the reliability of biomarkers in neuroscience research, supporting IXICO’s role in advancing biopharma services. Key IXICO scientists have also joined The Michael J. Fox Foundation’s MRI Advisory Committee to standardize MRI biomarkers for Parkinson’s disease.
FLSmidth & Co. A/S has repurchased 174,500 shares from June 1 to June 4, 2026, totaling DKK 88.9 million as part of its ongoing share buy-back program initiated on May 18, 2026. The program allows up to DKK 1 billion in buy-backs, with a maximum of 2...
Digital Realty has officially launched its Malaysia operations with a new data center campus in Cyberjaya, aiming to expand its capacity to 32 MW. This development integrates Malaysia into Digital Realty's global network, supporting AI and data-drive...
VCI Global Limited, through its subsidiary V Gallant Limited, announced the launch of Galactic OPC, an AI-native business operating system designed to help entrepreneurs and businesses efficiently build, operate, and scale in an AI-driven economy. Th...
VCI Global Limited, through its subsidiary V Gallant, announced the launch of Galactic OPC, an AI-native business operating system designed to help entrepreneurs and businesses operate efficiently in an AI-driven economy. The platform integrates inte...
Quantum Blockchain Technologies has overcome a key data challenge in developing its Method C AI Oracle, aiming to produce a first version by the end of June. The company successfully integrated a new ASIC manufacturer's Mining Development Kit with it...
